In patients, FMT has been shown to: improve insulin sensitivity in patients with metabolic syndrome [110], improve cognitive function in patients with cirrhosis and HE [111]; and restore antibiotic-associated disruption in microbial diversity and function in patients with advanced cirrhosis [112]. This evidence concerns the gene INS and Cirrhosis.